MRVI - Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A
IEX Last Trade
9.05
-0.160 -1.768%
Share volume: 1,143,319
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$9.21
-0.16
-1.74%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-04 | 2023-02-28 | 2023-05-09 | 2023-08-08 | 2023-11-08 | 2024-02-29 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 2.172 B | 2.249 B | 2.282 B | 2.315 B | 2.264 B | 2.268 B | 1.487 B | 1.445 B | |
| Current Assets | 759.382 M | 835.526 M | 847.902 M | 765.513 M | 699.312 M | 700.865 M | 699.912 M | 667.884 M | |
| Inventories | 60.113 M | 62.424 M | 43.152 M | 54.819 M | 47.402 M | 49.142 M | 51.397 M | 49.846 M | |
| Other Current Assets | 19.664 M | 23.432 M | 25.798 M | 25.532 M | 22.515 M | 22.916 M | 17.830 M | 16.818 M | |
| Short Term Investments | 19.664 M | 23.432 M | 25.798 M | 25.532 M | 22.515 M | 22.916 M | 17.830 M | 16.818 M | |
| Total Receivables | 128.929 M | 132.224 M | 146.814 M | 56.889 M | 49.219 M | 49.202 M | 55.723 M | 39.529 M | |
| Current Cash | 550.676 M | 617.446 M | 632.138 M | 628.273 M | 580.176 M | 579.605 M | 574.962 M | 561.691 M | |
| Total Non-current Assets | 1.412 B | 1.413 B | 1.434 B | 1.550 B | 1.565 B | 1.567 B | 787.538 M | 776.757 M | |
| Property Plant Equipment | 46.956 M | 48.420 M | 52.694 M | 87.721 M | 141.619 M | 153.565 M | 162.900 M | 161.628 M | |
| Other Assets | 25.190 M | 33.281 M | 115.589 M | 127.035 M | 92.735 M | 22.720 M | 77.622 M | 74.982 M | |
| Intangible Assets | 229.153 M | 222.899 M | 216.663 M | 241.578 M | 234.726 M | 227.856 M | 220.987 M | 214.118 M | |
| Goodwill | 283.535 M | 283.535 M | 283.668 M | 326.569 M | 326.459 M | 326.029 M | 326.029 M | 326.029 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.172 B | 2.249 B | 2.282 B | 2.315 B | 2.264 B | 2.268 B | 1.487 B | 1.445 B | |
| Total liabilities | 1.715 B | 1.745 B | 1.737 B | 1.794 B | 1.744 B | 1.748 B | 1.071 B | 1.034 B | |
| Total current liabilities | 112.530 M | 115.655 M | 110.144 M | 124.896 M | 74.919 M | 78.253 M | 87.468 M | 59.022 M | |
| Accounts Payable | 23.267 M | 9.459 M | 5.991 M | 4.784 M | 6.658 M | 9.424 M | 10.729 M | 8.226 M | |
| Other liabilities | 761.822 M | 724.961 M | 744.931 M | 743.444 M | 730.796 M | 738.732 M | 59.494 M | 58.623 M | |
| Current long term debt | 5.440 M | 5.440 M | 5.440 M | 5.740 M | 6.000 M | 6.036 M | 6.073 M | 6.112 M | |
| Long term debt | 523.655 M | 522.824 M | 521.997 M | 537.730 M | 552.572 M | 551.597 M | 550.604 M | 549.607 M | |
| Other liabilities | 761.822 M | 724.961 M | 744.931 M | 743.444 M | 730.796 M | 738.732 M | 59.494 M | 58.623 M | |
| Minority interest | 317.204 M | 337.908 M | 360.025 M | 379.121 M | 377.067 M | 372.987 M | 373.131 M | 366.730 M | |
| Total Shareholder equity | 456.588 M | 503.761 M | 545.218 M | 521.517 M | 520.571 M | 519.294 M | 416.753 M | 410.659 M | |
| Common stock | 131.524 M | 131.540 M | 131.627 M | 131.739 M | 131.864 M | 131.930 M | 132.143 M | 132.333 M | |
| Retained earnings | 322.663 M | 367.132 M | 404.766 M | 404.699 M | 398.158 M | 391.696 M | 285.737 M | 273.659 M |